Clinical assessment and management of foot and ankle osteoarthritis: a review of current evidence and focus on pharmacological treatment
Clinical assessment and management of foot and ankle osteoarthritis: a review of current evidence and focus on pharmacological treatment
Foot and ankle osteoarthritis (OA) is a common and disabling problem that adversely affects physical function and significantly reduces quality of life. Although the knee was considered to be the lower-limb site most often affected by OA, recent population data showed foot OA is as prevalent as knee OA, and rates increase with advancing years. The most common foot OA sites include the first metatarsophalangeal joint and the midfoot, with the ankle affected less often. Despite the high prevalence and disabling nature of foot and ankle OA, the condition has been neglected by clinical researchers, and there are very few trials investigating non-surgical foot or ankle OA treatment options. There are no accepted clinical diagnostic criteria for foot or ankle OA so imaging remains common. Clinical guidelines based on knee and hip OA research recommend education, exercise, and weight loss in the first instance. Topical non-steroidal anti-inflammatory drugs (NSAIDs) or capsaicin may be used as an adjunct. Failing these approaches, acetaminophen (paracetamol) should be recommended; however, if there is inadequate symptomatic relief, then clinicians should trial an oral NSAID or a cyclo-oxygenase-2 inhibitor. Given that adverse events and co-morbidities are common in the elderly, older patients should be closely monitored. Some studies have investigated intra-articular injections for foot and ankle OA, and there is some evidence to suggest hyaluronic acid may be effective in the short term for ankle OA. With the lack of research on foot or ankle OA treatments, however, robust clinical trials are urgently needed.
1-9
Paterson, Kade L.
30a53fee-5835-4ef4-9e76-2d963308fd55
Gates, Lucy
bc67b8b8-110b-4358-8e1b-6f1d345bd503
March 2019
Paterson, Kade L.
30a53fee-5835-4ef4-9e76-2d963308fd55
Gates, Lucy
bc67b8b8-110b-4358-8e1b-6f1d345bd503
Paterson, Kade L. and Gates, Lucy
(2019)
Clinical assessment and management of foot and ankle osteoarthritis: a review of current evidence and focus on pharmacological treatment.
Drugs and Aging, .
(doi:10.1007/s40266-019-00639-y).
Abstract
Foot and ankle osteoarthritis (OA) is a common and disabling problem that adversely affects physical function and significantly reduces quality of life. Although the knee was considered to be the lower-limb site most often affected by OA, recent population data showed foot OA is as prevalent as knee OA, and rates increase with advancing years. The most common foot OA sites include the first metatarsophalangeal joint and the midfoot, with the ankle affected less often. Despite the high prevalence and disabling nature of foot and ankle OA, the condition has been neglected by clinical researchers, and there are very few trials investigating non-surgical foot or ankle OA treatment options. There are no accepted clinical diagnostic criteria for foot or ankle OA so imaging remains common. Clinical guidelines based on knee and hip OA research recommend education, exercise, and weight loss in the first instance. Topical non-steroidal anti-inflammatory drugs (NSAIDs) or capsaicin may be used as an adjunct. Failing these approaches, acetaminophen (paracetamol) should be recommended; however, if there is inadequate symptomatic relief, then clinicians should trial an oral NSAID or a cyclo-oxygenase-2 inhibitor. Given that adverse events and co-morbidities are common in the elderly, older patients should be closely monitored. Some studies have investigated intra-articular injections for foot and ankle OA, and there is some evidence to suggest hyaluronic acid may be effective in the short term for ankle OA. With the lack of research on foot or ankle OA treatments, however, robust clinical trials are urgently needed.
Text
Clinical assessment and management of foot and ankle osteoarthritis: a review of current evidence and focus on pharmacological treatment
- Accepted Manuscript
More information
Accepted/In Press date: 1 January 2019
e-pub ahead of print date: 25 January 2019
Published date: March 2019
Identifiers
Local EPrints ID: 430008
URI: http://eprints.soton.ac.uk/id/eprint/430008
ISSN: 1170-229X
PURE UUID: 494fe323-8998-4b36-970d-fed21b3fb8f6
Catalogue record
Date deposited: 09 Apr 2019 16:30
Last modified: 16 Mar 2024 07:35
Export record
Altmetrics
Contributors
Author:
Kade L. Paterson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics